Mission: Empowerment

We began with a mission: to provide you with quality products that enhance your understanding of your own health. Our goal is to empower patients to take charge of their well-being by offering tools that help monitor vital signs and combat various diseases through a data-driven, holistic approach. We are here to support your journey towards a healthier life where you do not have to browse the internet for your symptoms.

Our Story

August

2023

NXTSTIM to partner with Kirloskar Technologies to deploy EcoAI within India.

July

2023

NXTSTIM reaches critical commercial milestone with over 1000 patients treated, over 300,000 treatments delivered, and over 6 million minutes of usage on NXTSTIM Ecosystem. Consistent and broad reimbursement from both private, medicare and medicare advantage plans.

May

2023

NXTSTIM and Medistar to partner to deploy EcoAI in Australia and New Zealand.

June

2022

CoachCare, a leading remote patient monitoring (RPM) and virtual health company, partners with NXTSTIM to provide the first ever commercial RPM solution for pain management with the EcoAI platform.

October

2021

NXTSTIM announces exclusive license and partnership with Teliatry LLC for manufacturing state of the art wafer device fabrication for Spinal Cord Stimulation (SCS), Dorsal Root Ganglion Stimulation (DRG), Peripheral Nerve Stimulation (PNS), and Deep Brain Stimulation (DBS) applications in chronic pain.

April

2021

Teliatry Awarded Phase 1 SBIR Grant From National Institute of Health to Develop Fully Implantable SCS Pain Management System.

December

2020

“NXTSTIM – Next Generation Stimulation Technology” formed by Dr. Krishnan Chakravarthy MD, PhD.

CEO’s Message

Dr. Krishnan Chakravarthy

M.D, PHD

NXTSTIM which stands for “Next Generation Stimulation Technologies”
was formed with three major overarching goals and a singular vision to provide greater access to care. Today, chronic pain affects one sixth of the human population and within the US there are more than 50 million americans annually that suffer from chronic pain. The biggest impediment to neuromodulation therapies is the cost and accessibility of these devices to patients. Given only roughly 100,000 implantable cases yearly, we are reaching about 0.2% of the addressable patients. I believe that to address this healthcare disparity we need to rely on a campaign that focuses on access, cost and community. These three key pillars of our vision form our “BetterTogether” campaign. Great technology must not be cost-prohibitive and provide access to our global community. If we are willing to dedicate ourselves to meaningful change, then we have the imperative to push innovation to match the needs of our patients at the front lines. I think we are on an incredible journey to revolutionize pain care by providing best in class devices with a true global digital ecosystem. I have never been more passionate or proud of our team, mission and vision at NXTSTIM. We are the future!

Our Team

Ben Barnes

Chief Commercialization Officer

Rahul Saini

Chief Technology Officer

Dr. Maja Green

Chief Science officer

Maria Kappell

Director of Implementation & Care Management Services

Shehryar Khalid

Marketing Director

Rayyan Adil

Director of Operations & Billing

Kip Theno

Executive Advisor

Sanjay Malkani

Executive Advisor